First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report

Omid Mozafari; Seyed Shorofi; Seyde Yousefi

First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report

Omid Mozafari
, Seyed Shorofi
, Seyde Yousefi

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).

Original language	English
Pages (from-to)	1217-1219
Number of pages	3
Journal	Iranian Journal of Public Health
Volume	45
Issue number	9
Publication status	Published - 27 Sept 2016

Keywords

Adverse reactions
Cutaneous leishmaniasis
Meglumine antimoniate (Glucantime)

Cite this

@article{fab5768870bc494abf9d22a1e70be9e1,

title = "First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report",

abstract = "Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother{\textquoteright}s parenteral use of meglumine antimoniate (glucantime).",

keywords = "Adverse reactions, Cutaneous leishmaniasis, Meglumine antimoniate (Glucantime)",

author = "Omid Mozafari and Seyed Shorofi and Seyde Yousefi",

year = "2016",

month = sep,

day = "27",

language = "English",

volume = "45",

pages = "1217--1219",

journal = "Iranian Journal of Public Health",

issn = "2251-6085",

publisher = "Tehran University of Medical Sciences",

number = "9",

}

TY - JOUR

T1 - First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report

AU - Mozafari, Omid

AU - Shorofi, Seyed

AU - Yousefi, Seyde

PY - 2016/9/27

Y1 - 2016/9/27

N2 - Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).

AB - Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).

KW - Adverse reactions

KW - Cutaneous leishmaniasis

KW - Meglumine antimoniate (Glucantime)

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149476/pdf/IJPH-45-1217.pdf

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149476/

UR - https://www.scopus.com/pages/publications/84988958794

M3 - Article

SN - 2251-6085

VL - 45

SP - 1217

EP - 1219

JO - Iranian Journal of Public Health

JF - Iranian Journal of Public Health

IS - 9

ER -

First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report

Abstract

Keywords

Other files and links

Fingerprint

Cite this